News - Metabolics, Generics


Current filters:


Popular Filters

Eternity and PharmaNova to develop branded medicines


Canadian medical device company Eternity Healthcare (OTC:ETAH) has signed a letter of intent with privately-held…

Eternity HealthcareGenericsMetabolicsPharmaceuticalPharmaNovaResearch

Par Pharma agrees $45 million settlement over off-label Megace ES promotion


US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6)…

FinancialGenericsLegalMarkets & MarketingMegace ESMetabolicsNorth AmericaPar PharmaceuticalPharmaceutical

AstraZeneca drops early-stage obesity drug; Roche loses out on Indian Tarceva dispute


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has told its development partner Palatin Technologies…

Asia-PacificAstraZenecaCiplaErlocipGenericsMetabolicsOncologyPalatin TechnologiesPatentsPharmaceuticalResearchRocheTarceva

Boca generic version of Tapazole cleared by FDA


Florida, USA-based privately-held Boca Pharmacal said on Friday that it has received approval from the…

Boca PharmacalGenericsKing PharmaceuticalsMetabolicsNorth AmericaRegulationTapazole

Back to top